Latin America Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

---

Industry Assessment Overview

Industry Findings: Regional supply-chain strengthening and coordinated public-health initiatives are creating a more predictable procurement horizon for diagnostics and monitoring suppliers. PAHO’s partnership with FIND to expand access to essential diagnostic tests in Latin America and the Caribbean is a concrete, region-level driver (Sep-2023). That collaboration has catalysed pooled procurement pilots and technical assistance to national labs, favouring vendors able to support multi-country rollouts, reagent continuity and training at scale.

Industry Progression: A single, verifiable region-level action that shifted procurement dynamics was PAHO’s 2024 annual activity and financing that explicitly prioritised laboratory and diagnostic capacity building across the Americas (PAHO Annual Report 2024). That public commitment translates into expanded tenders and project funding for lab analyzers, POC platforms and surveillance monitoring — a near-term demand signal for vendors ready to operationalise multi-country support.

Industry Player Insights: Key companies operating in this regional market include Roche Diagnostics, Abbott, Grupo Fleury, and Dasa etc. Regional procurement is tilting toward partnerships that combine global scale with local distribution: Roche and Abbott continue to supply high-throughput platforms and reagents, while Grupo Fleury and Dasa in Brazil extend lab-network capacity, demonstrating how blended global–regional supply models improve reagent availability and speed deployments across multi-country PAHO-backed programmes.